Breast Cancer Trial, Recruiting NCT07600957 Sponsor: Beni-Suef University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07600957
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 35 and 55 years old.
  • People who have been diagnosed with breast cancer in one breast only, confirmed through a tissue sample (biopsy).
  • People who have already had breast-conserving surgery (an operation that removes the tumour but keeps most of the breast).
  • People whose treatment plan includes a short course of radiation to the whole breast.
  • People scheduled to receive a total radiation dose of 40–42.5 Gy, given across 15–16 sessions over roughly 3 weeks.
  • People who are able to understand what the study involves and are willing to sign a consent form.

Who may not be able to join:

  • People who have previously had radiation treatment to the same breast or the chest area.
  • People who have cancer in both breasts.
  • People whose cancer has spread to other parts of the body.
  • People who have had the entire breast removed (mastectomy).
  • People who currently have a skin infection in the area where radiation would be given.
  • People who have an existing skin condition affecting the breast, such as eczema, psoriasis, or dermatitis.
  • People who are receiving chemotherapy at the same time as radiation treatment.
  • People who have a cardiac pacemaker or any implanted electronic medical device in or near the area to be treated.
  • People who have open wounds or ulcers on the breast to be treated.
  • People with any other health condition that the trial doctor considers would interfere with taking part in the study or affect how results are measured (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01141825442

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beni-Suef University
Registry
ClinicalTrials.gov
Start date
21 May 2026
Est. completion
15 January 2027

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Ultrasound Skin Thickness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov